Full Text View
Tabular View
No Study Results Posted
Related Studies
Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA)
This study is ongoing, but not recruiting participants.
Study NCT00907283   Information provided by Ente Ospedaliero Ospedali Galliera

First Received on May 21, 2009.   Last Updated on January 26, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neurodegenerative Disease
Iron Overload
Additional conditions recognized in this trial
Nerve Degeneration
Neuroaxonal Dystrophies
Neurodegenerative Diseases
Pantothenate Kinase-Associated Neurodegeneration
More general conditions related to this trial
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Genetic Diseases, Inborn
Heredodegenerative Disorders, Nervous System
Iron Metabolism Disorders
Metabolic Diseases
Movement Disorders
Nervous System Diseases
Pathologic Processes
Interventions listed in this trial
Deferiprone
More general drug interventions related to this trial
Chelating Agents
Iron Chelating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Sponsors listed in this trial
Ente Ospedaliero Ospedali Galliera


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services